Guy Griebel is the Head of Search and Evaluation for Rare and Neurological Disorders at Sanofi, where they lead efforts in evaluating innovative therapies. With over 20 years of experience, Guy has previously held prominent roles, including Global Head of the Department of Neuroscience Pharmacology, guiding cross-functional teams in the development of first-in-class compounds for various neurodegenerative and psychiatric disorders. Their pioneering research has identified crucial neurobiological roles and novel targets in mental diseases, significantly contributing to the field of neuropsychopharmacology. In addition to drug discovery, Guy has advanced the standardization of animal models for studying psychiatric and neurodegenerative disorders. They hold multiple degrees from Université de Strasbourg, culminating in a Ph.D. in Psychopharmacology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices